CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

4D Molecular Therapeutics, Inc. (FDMT) Reports Q2 Loss, Tops Revenue Estimates

EarningsNeutral
AI Analysis

Summary

4D Molecular Therapeutics reported Q2 2026 results with a net loss and revenue that exceeded estimates.

Importance:2/10
Sentiment:
0.00
earningsQ2 resultsrevenue
Related Companies

Read the original article

Published by yahoo_finance on August 13, 2026 10:05 PM

Read Original